Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Theravance Biopharma R&D IP, LLC”

252 pharma patents match "Theravance Biopharma R&D IP, LLC" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 252
Index total 30,257
Page 5 / 11

Quick answer

This filtered view shows 252 pharmaceutical patents matching "Theravance Biopharma R&D IP, LLC" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

252 results for “Theravance Biopharma R&D IP, LLC” · 30,257 patents in full index Clear search

  1. US 10485803

    Pyrimidine compounds as JAK kinase inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Nov 26, 2019 · Expires Nov 21, 2039

    granted
  2. US 10472366

    Glucuronide prodrugs of tofacitinib

    Theravance Biopharma R&D IP, LLC · Granted Nov 12, 2019 · Expires Nov 7, 2039

    granted
  3. US 10472335

    Crystalline(2S,4R)-5-(5′-chloro-2′-fluoro-[1,1′-bipheny]-4-yl)-2-(ethoxymethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2-methylpentanoic acid and uses thereof

    Theravance Biopharma R&D IP, LLC · Granted Nov 12, 2019 · Expires Nov 7, 2039

    granted
  4. US 10441579

    4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds

    Theravance Biopharma R&D IP, LLC · Granted Oct 15, 2019 · Expires Oct 10, 2039

    granted
  5. US 10435428

    Prodrugs of a JAK inhibitor compound for treatment of gastrointestinal inflammatory disease

    Theravance Biopharma R&D IP, LLC · Granted Oct 8, 2019 · Expires Oct 3, 2039

    granted
  6. US 10426766

    Crystalline forms of an 8-azabicyclo[3.2.1]octane compound

    Theravance Biopharma R&D IP, LLC · Granted Oct 1, 2019 · Expires Sep 26, 2039

    granted
  7. US 10406148

    Methods of treatment using a JAK inhibitor compound

    Theravance Biopharma R&D IP, LLC · Granted Sep 10, 2019 · Expires Sep 5, 2039

    granted
  8. US 10392368

    Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Aug 27, 2019 · Expires Aug 22, 2039

    granted
  9. US 10392386

    JAK inhibitors containing a 4-membered heterocyclic amide

    Theravance Biopharma R&D IP, LLC · Granted Aug 27, 2019 · Expires Aug 22, 2039

    granted
  10. US 10377751

    8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists

    Theravance Biopharma R&D IP, LLC · Granted Aug 13, 2019 · Expires Aug 8, 2039

    granted
  11. US 10369142

    Combination dosage form of a mu opioid receptor antagonist and an opioid agent

    Theravance Biopharma R&D IP, LLC · Granted Aug 6, 2019 · Expires Aug 1, 2039

    granted
  12. US 10343995

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance Biopharma R&D IP, LLC · Granted Jul 9, 2019 · Expires Jul 4, 2039

    granted
  13. US 10336773

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Jul 2, 2019 · Expires Jun 27, 2039

    granted
  14. US 10315984

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Jun 11, 2019 · Expires Jun 6, 2039

    granted
  15. US 10308646

    Pyrimidine compound as JAK kinase inhibitor

    Theravance Biopharma R&D IP, LLC · Granted Jun 4, 2019 · Expires May 30, 2039

    granted
  16. US 10251874

    Crystalline forms of a JAK inhibitor compound

    Theravance Biopharma R&D IP, LLC · Granted Apr 9, 2019 · Expires Apr 4, 2039

    granted
  17. US 10238642

    Methods for treating neurogenic orthostatic hypotension

    Theravance Biopharma R&D IP, LLC · Granted Mar 26, 2019 · Expires Mar 21, 2039

    granted
  18. US 10233172

    Benzimidazole-carboxamide compounds as 5-HT4 receptor agonists

    Theravance Biopharma R&D IP, LLC · Granted Mar 19, 2019 · Expires Mar 14, 2039

    granted
  19. US 10233174

    Thiocarbamate prodrugs of tofacitinib

    Theravance Biopharma R&D IP, LLC · Granted Mar 19, 2019 · Expires Mar 14, 2039

    granted
  20. US 10226454

    Crystalline form of a 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compound

    Theravance Biopharma R&D IP, LLC · Granted Mar 12, 2019 · Expires Mar 7, 2039

    granted
  21. US 10208040

    Fused imidazo-piperidine JAK inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Feb 19, 2019 · Expires Feb 14, 2039

    granted
  22. US 10206913

    4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds

    Theravance Biopharma R&D IP, LLC · Granted Feb 19, 2019 · Expires Feb 14, 2039

    granted
  23. US 10196393

    JAK inhibitors containing a 4-membered heterocyclic amide

    Theravance Biopharma R&D IP, LLC · Granted Feb 5, 2019 · Expires Jan 31, 2039

    granted
  24. US 10189823

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Jan 29, 2019 · Expires Jan 24, 2039

    granted